SHAREKHAN OPTIMISTIC ON CADILA HEALTHCARE STOCK'S PROSPECTS; RECOMMENDS A BUY WITH PRICE TARGET OF RS 720

© Provided by Zee Business Brokerage firm Sharekhan says that Cadila Healthcare said that the company is making concentrated efforts to build a strong presence in areas of complex generics, injectable, and specialty portfolios in the US, which offer strong growth potential, which could unfold over the medium to long term. It recommends a buy on this stock with a target price of Rs 720. ...

Source: